HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oscar Millet Selected Research

Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)

6/2021Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy.
5/2021Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria.
1/2018Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.
1/2017Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
11/2014Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria.
11/2013Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
4/2011Intracellular rescue of the uroporphyrinogen III synthase activity in enzymes carrying the hotspot mutation C73R.
1/2011Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase: molecular basis of congenital erythropoietic porphyria.
1/2009Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oscar Millet Research Topics

Disease

10Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
06/2021 - 01/2009
6Fibrosis (Cirrhosis)
10/2022 - 01/2016
4COVID-19
01/2022 - 01/2020
3Non-alcoholic Fatty Liver Disease
10/2022 - 01/2021
3Infections
01/2022 - 12/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2017
2Liver Diseases (Liver Disease)
01/2022 - 01/2017
2Tyrosinemias (Tyrosinemia)
02/2021 - 01/2019
2Hemolytic Anemia
01/2017 - 11/2013
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Inflammation (Inflammations)
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Severe Acute Respiratory Syndrome
01/2022
1Disease Progression
12/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
07/2021
1Anemia
06/2021
1Starvation
01/2021
1Insulin Resistance
01/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1Rare Diseases (Rare Disease)
01/2021
1Neoplasms (Cancer)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Trimethylaminuria
10/2019
1Ketosis
10/2019
1X-Linked Bulbo-Spinal Atrophy
01/2019
1Acute Intermittent Porphyria (Porphyria, Acute)
11/2018
1Pathologic Processes
05/2014

Drug/Important Bio-Agent (IBA)

9Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
06/2021 - 01/2009
7EnzymesIBA
10/2022 - 01/2011
5PorphyrinsIBA
01/2022 - 11/2013
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
5Heme (Haem)IBA
06/2021 - 01/2011
3Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2014
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2022 - 01/2021
3Lipoproteins (Lipoprotein)IBA
01/2022 - 01/2021
3Choline (Choline Chloride)IBA
01/2022 - 01/2016
2Polysaccharides (Glycans)IBA
01/2022 - 12/2020
2Methionine AdenosyltransferaseIBA
01/2022 - 01/2021
2ApolipoproteinsIBA
01/2022 - 01/2021
2Ciclopirox (Loprox)FDA LinkGeneric
05/2021 - 01/2018
2acetoacetic acid (acetoacetate)IBA
02/2021 - 01/2016
2Pharmaceutical PreparationsIBA
01/2018 - 05/2014
2Proteasome InhibitorsIBA
01/2017 - 11/2013
1very low density lipoprotein triglycerideIBA
10/2022
1Phospholipases (Phospholipase)IBA
10/2022
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
01/2022
1IsomerasesIBA
01/2022
1Methionine (L-Methionine)FDA Link
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Protons (Proton)IBA
01/2022
1Bovine Serum AlbuminIBA
01/2022
1VaccinesIBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1LipidsIBA
07/2021
1Ferritins (Ferritin)IBA
06/2021
1fumarylacetoacetateIBA
02/2021
1succinylacetoneIBA
02/2021
1HydrolasesIBA
02/2021
1HDL LipoproteinsIBA
01/2021
1IronIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1LectinsIBA
12/2020
1CarbonIBA
01/2020
1NitrogenIBA
01/2020
1Urea (Carbamide)FDA LinkGeneric
01/2020
1trimethylamineIBA
10/2019
1fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA
01/2019
1polyglutamineIBA
01/2019
1Androgen Receptors (Androgen Receptor)IBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2019
1Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
11/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017
1SphingomyelinsIBA
01/2017
1Bile Acids and Salts (Bile Acids)IBA
01/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2016

Therapy/Procedure

1Therapeutics
01/2017
1Liver Transplantation
01/2017